These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21590393)

  • 1. Host cells and cell banking.
    Stacey GN; Merten OW
    Methods Mol Biol; 2011; 737():45-88. PubMed ID: 21590393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated viruses.
    Mezzina M; Merten OW
    Methods Mol Biol; 2011; 737():211-34. PubMed ID: 21590399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.
    Ghani K; Wang X; de Campos-Lima PO; Olszewska M; Kamen A; Rivière I; Caruso M
    Hum Gene Ther; 2009 Sep; 20(9):966-74. PubMed ID: 19453219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of current scalable methods for purification of viral vectors.
    Segura MM; Kamen AA; Garnier A
    Methods Mol Biol; 2011; 737():89-116. PubMed ID: 21590394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manufacturing of adeno-associated viruses, for example: AAV2.
    Chen H
    Methods Mol Biol; 2011; 737():235-46. PubMed ID: 21590400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
    Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
    J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
    Mitta B; Rimann M; Fussenegger M
    Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector characterization methods for quality control testing of recombinant adeno-associated viruses.
    Wright JF; Zelenaia O
    Methods Mol Biol; 2011; 737():247-78. PubMed ID: 21590401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopreservation and banking of mammalian cell lines.
    Stacey GN; Masters JR
    Nat Protoc; 2008; 3(12):1981-9. PubMed ID: 19180080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.
    Silva AC; Simão D; Küppers C; Lucas T; Sousa MF; Cruz P; Carrondo MJ; Kochanek S; Alves PM
    Biotechnol J; 2015 May; 10(5):760-71. PubMed ID: 25943527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vectors.
    Giry-Laterrière M; Verhoeyen E; Salmon P
    Methods Mol Biol; 2011; 737():183-209. PubMed ID: 21590398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
    Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
    J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies and methods for the detection and identification of viral vectors.
    Stellberger T; Koehler N; Dinkelmeier A; Draxler J; Haase M; Hellinckx J; Pavlovic M; Busch U; Baiker A
    Virus Genes; 2017 Oct; 53(5):749-757. PubMed ID: 28725978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
    Côté J; Garnier A; Massie B; Kamen A
    Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy: promises and problems.
    Pfeifer A; Verma IM
    Annu Rev Genomics Hum Genet; 2001; 2():177-211. PubMed ID: 11701648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale production means for the manufacturing of lentiviral vectors.
    Schweizer M; Merten OW
    Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral vectors for gene delivery to corneal endothelial cells].
    Fuchsluger TA; Jurkunas U; Kazlauskas A; Dana R
    Klin Monbl Augenheilkd; 2011 Jun; 228(6):498-503. PubMed ID: 21656431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.